first week of glp 1 What to Expect During the Semaglutide GLP-1R Agonists for Weight Loss
Description
While there are currently no specific drugs approved for treatment, research is being done on how GLP-1s may be able to halt or even reverse NAFLD

In April 2025, AstraZeneca Plc could receive European Medicines Agency (EMA) approval for ECC5004, its oral GLP-1RA, for the treatment of obesity, intensifying competition in the oral treatment segment

Current data indicates 137 million Americans meet eligibility criteria for semaglutide, the active ingredient found in Ozempic and Wegovy

The agency identified the lot number (NAR0074) and the serial number (430834149057) of the affected products but warned they could still be available

GLP-1 medications already reduce food intake by 2540% in early trials